Literature DB >> 17873382

The flawed scientific basis of the altered nuclear transfer-oocyte assisted reprogramming (ANT-OAR) proposal.

W Malcolm Byrnes1.   

Abstract

First put forth in June 2005, the altered nuclear transfer-oocyte assisted reprogramming (ANT-OAR) proposal has been promoted as an ethically-acceptable alternative to the embryo-destructive methods now used to obtain embryonic stem cells. According to its proponents, the goal of ANT-OAR is to use the cloning process to create a pluripotent stem cell. This would be achieved through overexpression of the transcription factor Nanog (or a hypothetical substitute) both in the enucleated egg cell and in the somatic cell prior to transfer of its nucleus. Although the ethical acceptability of ANT-OAR has been publicly debated, its scientific feasibility has not. This paper aims to help rectify this situation. It argues that ANT-OAR, as currently conceived, cannot realistically work. It presents evidence from the scientific literature showing that Nanog cannot single-handedly establish pluripotency in cells, but rather works together with a network of other transcription factors to maintain pluripotency. It argues that ANT-OAR is based on a flawed understanding of stem cell biology, and emphasizes that, in this debate about embryonic stem cells, scientists must strive to accurately and realistically assess the feasibility of the embryo research strategies they propose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873382     DOI: 10.1007/s12015-007-0014-6

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  28 in total

1.  Cdx2 is essential for axial elongation in mouse development.

Authors:  Kallayanee Chawengsaksophak; Wim de Graaff; Janet Rossant; Jacqueline Deschamps; Felix Beck
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

2.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal.

Authors:  Guangjin Pan; Jun Li; Yali Zhou; Hui Zheng; Duanqing Pei
Journal:  FASEB J       Date:  2006-06-21       Impact factor: 5.191

4.  Production of pluripotent stem cells by oocyte-assisted reprogramming: joint statement with signatories.

Authors:  Hadley Arkes; Nicanor Pier Giorgio Austriaco; Thomas Berg; E Christian Brugger; Nigel M de S Cameron; Joseph Capizzi; Maureen L Condic; Samuel B Condic; Kevin T FitzGerald; Kevin Flannery; Edward J Furton; Robert P George; Timothy George; Alfonso Gomez-Lobo; Germain Grisez; Markus Grompe; John M Haas; Robert Hamerton-Kelly; John Collins Harvey; Paul J Hoehner; William B Hurlbut; John F Kilner; Patrick Lee; William E May; Gonzalo Miranda; C Ben Mitchell; John J Myers; Chris Oleson; Tad Pacholczyk; Peter F Ryan; William L Saunders; David Stevens; Stuart W Swetland; M Edward Whelan; Thomas Williams
Journal:  Natl Cathol Bioeth Q       Date:  2005

5.  Editorial expression of concern.

Authors:  Donald Kennedy
Journal:  Science       Date:  2006-10-27       Impact factor: 47.728

6.  The moral case for ANT-derived pluripotent stem cell lines.

Authors:  Nicanor Pier Giorgio Austriaco
Journal:  Natl Cathol Bioeth Q       Date:  2006

7.  Cloning special: Dolly: a hard act to follow.

Authors:  Erika Check
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962

8.  Transcriptional regulation of nanog by OCT4 and SOX2.

Authors:  David J Rodda; Joon-Lin Chew; Leng-Hiong Lim; Yuin-Han Loh; Bei Wang; Huck-Hui Ng; Paul Robson
Journal:  J Biol Chem       Date:  2005-04-27       Impact factor: 5.157

9.  Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts.

Authors:  Alexander Meissner; Rudolf Jaenisch
Journal:  Nature       Date:  2005-10-16       Impact factor: 49.962

Review 10.  The first cell-fate decisions in the mouse embryo: destiny is a matter of both chance and choice.

Authors:  Magdalena Zernicka-Goetz
Journal:  Curr Opin Genet Dev       Date:  2006-06-23       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.